By Gene Emery Gout sufferers with major pre-existing heart disease face a higher risk of death if they are treated with the drug febuxostat, a large long-term study has concluded The risk of death from cardiovascular disease was 34 percent higher with febuxostat than with an older drug, allopurinol. When researchers considered deaths from any […]

The post Newer Gout Drug Poses Risk to Heart Patients appeared first on OMG News Today.